Incyte (INCY) Asset Utilization Ratio (2011 - 2026)
Incyte's (INCY) quarterly Asset Utilization Ratio came in at 0.77 in Q2 2026, down 3.45% YoY from 0.79 in Q2 2025, and up 2.03% on a QoQ basis from 0.75 in Q1 2026.
Analysis
Incyte (INCY) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Incyte (INCY) has 16 years of Asset Utilization Ratio data on file, last reported at 0.77 in Q2 2026.
- Quarterly Asset Utilization Ratio fell 3.45% year-over-year to 0.77 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.77 (down 3.45% YoY) and the FY2025 annual result came in at 0.83, up 19.5% from the prior year.
- Asset Utilization Ratio grew to 0.77 in Q2 2026, from 0.75 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.84 in Q3 2024 to a low of 0.54 in Q1 2024.
- A 5-year average of 0.68 and a median of 0.65 in 2022 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio fell 16.67% — and 2024, when it jumped 47.05%.
- Tracing INCY's Asset Utilization Ratio over 5 years: stood at 0.6 in 2022, then retreated by 6.17% to 0.56 in 2023, then soared by 44.54% to 0.81 in 2024, then slipped by 4.61% to 0.77 in 2025, then slipped by 1.12% to 0.77 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.77 (Q2 2026), 0.75 (Q1 2026), and 0.77 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | 0.20 |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 0.69 |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 0.90 |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | 0.13 |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 0.54 |
| 10 | Incyte | 25.59 Bn | 21.05 Bn | 1.57 Bn | 0.77 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.77 |
| Mar 31, 2026 | 0.75 |
| Dec 31, 2025 | 0.77 |
| Sep 30, 2025 | 0.79 |
| Jun 30, 2025 | 0.79 |
| Mar 31, 2025 | 0.79 |
| Dec 31, 2024 | 0.81 |
| Sep 30, 2024 | 0.84 |
| Jun 30, 2024 | 0.65 |
| Mar 31, 2024 | 0.54 |
| Dec 31, 2023 | 0.56 |
| Sep 30, 2023 | 0.57 |
| Jun 30, 2023 | 0.59 |
| Mar 31, 2023 | 0.60 |
| Dec 31, 2022 | 0.60 |
| Sep 30, 2022 | 0.62 |
| Jun 30, 2022 | 0.64 |
| Mar 31, 2022 | 0.62 |
| Dec 31, 2021 | 0.65 |
| Sep 30, 2021 | 0.72 |